Navigation Links
Qualitas Health and Valicor Renewables Announce Strategic Partnership to Commercialize Algae-Based Omega-3 Supplements

JERUSALEM, DEXTER, Michigan, February 11, 2013 /PRNewswire/ --

Qualitas Health and Valicor Renewables announced today a strategic partnership that will accelerate the launch of high-EPA Omega-3 oil from algae. The companies have joined forces to combine their expertise and experience in biology, advanced chemistry and technology commercialization to make a significant impact on the global Omega-3 market with next-generation algae based products.



"We are excited to work with Valicor Renewables as our strategic extraction partner" says Dr. Isaac Berzin , CTO of Qualitas Health. "Exclusive access to Valicor's extraction technology gives us a significant technological advantage and reduces the time-to-market of our pure-EPA omega-3 oil from algae. Valicor's technology is proven and practical. It completes the necessary portfolio of technologies needed to manufacture an algae-based Omega-3 supplement on a commercial scale."

"The collaboration between Qualitas and Valicor brings together best-in-class cultivation and strain technology with best-in-class class extraction technology, protected by robust patents" says Dr. Brian Goodall , VP. Business Development at Valicor Renewables. "Valicor's extraction technology is designed to keep the natural algae polar lipids intact while avoiding the use of potentially harmful solvents".

About Qualitas Health:

Qualitas Health is a privately-held company developing high-value vegetarian food supplements and pharmaceutical ingredients based on microalgae. Building on over 10 years' experience in algae cultivation and extraction from the biofuel sector, the company's team has developed a unique and proprietary technology for strain selection, sustainable algae farming, harvesting and oil processing. The technology allows for the effective production of proprietary premium Omega-3 algae oil for a wide range of applications.

About Valicor Renewables   (formerly SRS Energy):

Headquartered in Dexter, Michigan, Valicor services clients throughout the United States in the automotive, aerospace, alternative fuels, algae-derived products, power generation, and steel industries. The company operates three business groups, Environmental Services, Separation Technologies and Renewables, concentrating on the advancement of its technologies in processes and fluid management to meet client needs.  Since beginning the Algae Extraction Program in 2007, Valicor Renewables has established transformative new techniques for the extraction and fractionation of algae oil.  The development of the patent pending Valicor Algafrac™ technologies has provided for commercially scalable processes which efficiently and cost-effectively extract both polar and non-polar lipids.

Yuri Shoshan

SOURCE Qualitas Health Ltd
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. The California Healthcare Institute Responds to New Efforts to Repeal the Federal Medical Device Excise Tax
2. Trovagene to Present at Leerink Swan Global Healthcare Conference
3. EU Study Finds UK Health Product Benefit Metric Flawed
4. Novus International And Verenium Announce Important Progress In The Development Of Novel Enzymes For Animal Health & Nutrition
5. Healthcare Sales Jobs Rising Despite Challenges Facing the Industry
6. Life Technologies to Present at Leerink Swann Global Healthcare Conference
7. Topricin Pain Relief and Healing Cream Selected by Healthy Holistic Living as one of the Top 100 Green Products of 2012
8. Nutrex Hawaii Hawaiian Astaxanthin Microalgae May be the Secret to Better Eye Health
9. Providence Health & Services Selects Conflict of Interest Management System
10. California Healthcare Institute Appoints Allergan CEO Chairman of the Board, Elects New Board Members
11. Dr. Alexander Fleming on Searching for Solutions to Metabesity and Healthy Aging
Post Your Comments:
(Date:11/26/2015)... November 26, 2015 --> ... specializing in imaging technologies, announced today that it has received ... of the Horizon 2020 European Union Framework Programme for Research ... clinical trial in breast cancer. , --> ... --> --> The study aims ...
(Date:11/25/2015)...  PharmAthene, Inc. (NYSE MKT: PIP) announced  today that ... plan (Rights Plan) in an effort to preserve the ... Section 382 of the Internal Revenue Code (Code). ... of its NOLs could be substantially limited if the ... 382 of the Code. In general, an ownership change ...
(Date:11/25/2015)... Studies reveal the differences in ... pave the way for more effective treatment for one of ...   --> --> Gum ... in cats, yet relatively little was understood about the bacteria ... been conducted by researchers from the WALTHAM Centre for Pet ...
(Date:11/25/2015)...  Neurocrine Biosciences, Inc. (Nasdaq: NBIX ) announced ... of Neurocrine Biosciences, will be presenting at the 27th ... York . .   ... minutes prior to the presentation to download or install ... be available on the website approximately one hour after ...
Breaking Biology Technology:
(Date:11/16/2015)... , Nov 16, 2015  Synaptics Inc. (NASDAQ: ... interface solutions, today announced expansion of its TDDI ... touch controller and display driver integration (TDDI) ... smartphones. These new TDDI products add to the ... resolution), TD4302 (WQHD resolution), and TD4322 (FHD resolution) ...
(Date:11/11/2015)... , Nov. 11, 2015   MedNet Solutions , ... spectrum of clinical research, is pleased to announce that it ... Clinical Trials (PCT) event, to be held November 17-19 ... able to view live demonstrations of iMedNet ... learn how iMedNet has been able to deliver ...
(Date:11/9/2015)... SAN JOSE, Calif. , Nov. 9, 2015 /PRNewswire/ ... of human interface solutions, today announced broader entry into ... of vehicle-specific solutions that match the pace of consumer ... drivers, and biometric sensors are ideal for the automotive ... the vehicle. Europe , ...
Breaking Biology News(10 mins):